Modulation of receptor and receptor subtype affinities using diastereomeric and enantiomeric monosaccharide scaffolds as a means to structural and biological diversity. A new route to ether synthesis

被引:117
作者
Hirschmann, R
Hynes, J
Cichy-Knight, MA
van Rijn, RD
Sprengeler, PA
Spoors, PG
Shakespeare, WC
Pietranico-Cole, S
Barbosa, J
Liu, J
Yao, WQ
Rohrer, S
Smith, AB [1 ]
机构
[1] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA
[2] Merck & Co Inc, Merck Sharp & Dohme Res Labs, Rahway, NJ 07065 USA
关键词
D O I
10.1021/jm9800346
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We show that carbohydrates constitute an attractive source of readily available, stereochemically defined scaffolds for the facile attachment of side chains contained in genetically encoded and other amino acids. beta-D- and beta-L-glucose, L-mannose, and the 6-deoxy-6-N-analogue of beta-D-glucose have been employed to synthesize peptidomimetics that bind the SRIF receptors on AtT-20 mouse pituitary cells, five cloned human receptor subtypes (hSSTRs), and the NK-1 receptor. The affinity profile of various sugar-based ligands at the hSSTRs is compared with that of SRIF. Compound 19 bound hSSTR4 with a K-i of 100 nM. Subtle structural changes affect affinities. Evidence is presented that suggests that one compound (8) binds both the AtT-20 cell receptors and the five hSSTRs via a unique mode. The SARs of the glycosides at SRIF receptors differ markedly from those at the NK-1 receptor. For example a 4-benzyl substituent is important for SRIF receptor binding, but the 4-desbenzyl analogue 27 was highly potent (IC50 of 27 nM) at the NK-1 receptor. A new, nonbasic method for the synthesis of base-sensitive ethers from primary and secondary alcohols is also described.
引用
收藏
页码:1382 / 1391
页数:10
相关论文
共 82 条
[1]  
[Anonymous], 1996, REV COMP CH
[2]   ON THE LOW-ENERGY SOLUTION CONFORMATION OF SOMATOSTATIN [J].
ARISON, BH ;
HIRSCHMANN, R ;
PALEVEDA, WJ ;
BRADY, SF ;
VEBER, DF .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1981, 100 (03) :1148-1153
[3]   INFERENCES ABOUT THE CONFORMATION OF SOMATOSTATIN AT A BIOLOGIC RECEPTOR BASED ON NMR-STUDIES [J].
ARISON, BH ;
HIRSCHMANN, R ;
VEBER, DF .
BIOORGANIC CHEMISTRY, 1978, 7 (04) :447-451
[4]   Unexpected binding mode of a cyclic sulfamide HIV-1 protease inhibitor [J].
Backbro, K ;
Lowgren, S ;
Osterlund, K ;
Atepo, J ;
Unge, T ;
Hulten, J ;
Bonham, NM ;
Schaal, W ;
Karlen, A ;
Hallberg, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (06) :898-902
[5]  
BAUER W, 1982, LIFE SCI, V31, P1133, DOI 10.1016/0024-3205(82)90087-X
[6]   EXO-6-BENZYL-EXO-2-(META-HYDROXYPHENYL)-1-DIMETHYLAMINOMETHYLBICYCLO[2.2.2.]OCTANE - A NONPEPTIDE MIMIC OF ENKEPHALINS [J].
BELANGER, PC ;
DUFRESNE, C .
CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE, 1986, 64 (08) :1514-1520
[7]   IN-VITRO AND IN-VIVO EVIDENCE FOR A TACHYKININ NK1 RECEPTOR ANTAGONIST EFFECT OF VAPREOTIDE, AN ANALGESIC CYCLIC ANALOG OF SOMATOSTATIN [J].
BETOIN, F ;
ADVENIER, C ;
FARDIN, V ;
WILCOX, G ;
LAVARENNE, J ;
ESCHALIER, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 279 (2-3) :241-249
[8]   ON THE INVITRO AND INVIVO ACTIVITY OF A NEW SYNTHETIC HEXAPEPTIDE THAT ACTS ON THE PITUITARY TO SPECIFICALLY RELEASE GROWTH-HORMONE [J].
BOWERS, CY ;
MOMANY, FA ;
REYNOLDS, GA ;
HONG, A .
ENDOCRINOLOGY, 1984, 114 (05) :1537-1545
[9]   APPROACHES TO PEPTIDOMIMETICS WHICH SERVE AS SURROGATES FOR THE CIS AMIDE BOND - NOVEL DISULFIDE-CONSTRAINED BICYCLIC HEXAPEPTIDE ANALOGS OF SOMATOSTATIN [J].
BRADY, SF ;
PALEVEDA, WJ ;
ARISON, BH ;
SAPERSTEIN, R ;
BRADY, EJ ;
RAYNOR, K ;
REISINE, T ;
VEBER, DF ;
FREIDINGER, RM .
TETRAHEDRON, 1993, 49 (17) :3449-3466
[10]   ISOLATION OF SOMATOSTATIN (A SOMATOTROPIN-RELEASE-INHIBITING-FACTOR) OF OVINE HYPOTHALAMIC ORIGIN [J].
BRAZEAU, P ;
VALE, W ;
BURGUS, R ;
GUILLEMIN, R .
CANADIAN JOURNAL OF BIOCHEMISTRY, 1974, 52 (11) :1067-1072